BMS 540215,
BMS 582664,
BMS-540215,
BMS-582664,
BMS540215,
BMS582664,
brivanib,
brivanib alaninate,
Brivanib alaninate,
649735-63-7,
BMS-582664,
Brivanib alaninate (BMS-582664),
BMS582664,
Brivanib (alaninate),
UNII-U2Y5OFN795,
BMS 582664,
U2Y5OFN795,
(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-yl (2S)-2-aminopropanoate,
brivanib alinate,
Brivanib alaninate [USAN:INN],
Brivanib-alaninate,
SCHEMBL483382,
CHEMBL270995,
GTPL8097,
KS-00000XPL,
DTXSID20215295,
EX-A012,
SYN1135,
Brivanib alaninate,BMS-582664,
BCP01783,
L-Alanine,(1R)-2-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-1-methylethylester,
Brivanib alaninate (JAN/USAN/INN),
Brivanib alaninate - BMS-582664,
s1138,
ZINC29134440,
AKOS025401744,
CS-0159,
DB11865,
RL04475,
SB16530,
AC-25066,
AN-27666,
AS-16274,
BC630637,
HY-10336,
L-Alanine, (1R)-2-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl ester,
A2633,
FT-0663602,
SW219897-1,
A20636,
D08878,
W-5958,
J-519933,
BMS-582664, 649735-63-7,
(1R)-2-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1- f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl (2S)-2-aminopropanoate,
(S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-yl) 2-aminopropanoate,
[(1R)-2-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy-1-methyl-ethyl] (2S)-2-aminopropanoate,
[(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[5,1-f][1,2,4]triazin-6-yl]oxypropan-2-yl] (2S)-2-aminopropanoate,
L-Alanine, (1R)-2-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5- methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)oxy)-1-methylethyl ester,
D03WQS,
cc-420,
Brivanib alaninate (INN/USAN),
C22H24FN5O4,
BMS-582664, Brivanib alaninate,
CID11154925,
CID 11154925,
A10162,
(R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yloxy)propan-2-ol,